organization · Reporting owner
Franchise Brands, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PURE BIOSCIENCE, INC.
Report date December 29, 2017 · Filed December 29, 2017
Section 16 reporting ended · disclosed 2017-12-29. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 1
1 source rowRow 1 · 2017-12-29 · Sale · Disposed 18,666,666 · Balance 0 F1: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. |
| WarrantSEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2019-08-22 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-12-29 · Sale · Disposed 2,133,333 · Balance 0 F1: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2017 Filed Dec 29, 2017 22:11 UTC | PURE BIOSCIENCE, INC. PURE · Entity 7969 | SaleWarrant · Derivative | 2,133,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001209191-17-067658 · doc4.xml · derivative · entry 2 Franchise Brands, LLC · CIK 0001618371 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,133,333 shares Expires 2019-08-22 F1 · kind: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. F1 · price: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. Read SEC document |
| December 29, 2017 Filed Dec 29, 2017 22:11 UTC | PURE BIOSCIENCE, INC. PURE · Entity 7969 | SaleCommon Stock | 18,666,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-067658 · doc4.xml · nonDerivative · entry 1 Franchise Brands, LLC · CIK 0001618371 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. F1 · price: Represents a private sale under the terms of a Securities Transfer Agreement between Reporting Person and Plum Investments, L.P. for an aggregate purchase price of $8,399,999.70. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.